Pharma groups slam EU’s compulsory licensing proposal
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyComplianceGlobalPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyComplianceGlobalPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy